Literature DB >> 22677576

Muscle trigger points, pressure pain threshold, and cervical range of motion in patients with high level of disability related to acute whiplash injury.

Antonio Manuel Fernández-Pérez1, Carmen Villaverde-Gutiérrez, Aurora Mora-Sánchez, Cristina Alonso-Blanco, Michele Sterling, César Fernández-de-Las-Peñas.   

Abstract

STUDY
DESIGN: Cross sectional cohort study.
OBJECTIVE: To analyze the differences in the prevalence of trigger points (TrPs) between patients with acute whiplash-associated disorders (WADs) and healthy controls, and to determine if widespread pressure hypersensitivity and reduced cervical range of motion are related to the presence of TrPs in patients with acute WADs.
BACKGROUND: The relationship between active TrPs and central sensitization is not well understood in patients with acute WADs.
METHODS: Twenty individuals with a high level of disability related to acute WAD and 20 age- and sex-matched controls participated in the study. TrPs in the temporalis, masseter, upper trapezius, levator scapulae, sternocleidomastoid, suboccipital, and scalene muscles were examined. TrPs are defined as hypersensitive spots in a palpable taut band, producing a local twitch response and referred pain when palpated. Pressure pain threshold (PPT) was assessed bilaterally over the C5-6 zygapophyseal joints, second metacarpal, and tibialis anterior muscle. Active cervical range of motion, neck pain, and self-rated disability using the Neck Disability Index were also assessed.
RESULTS: The mean ± SD number of TrPs for the patients with acute WAD was 7.3 ± 2.8 (3.4 ± 2.7 were latent TrPs; 3.9 ± 2.5 were active TrPs). In comparison, healthy controls had 1.7 ± 2.2 latent and no active TrPs (P<0.01). In patients with acute WAD, the most prevalent sites for active TrPs were the levator scapulae and upper trapezius muscles. The number of active TrPs increased with higher neck pain intensity (P<0.001) and a higher number of days since the accident (P=.003). Patients had significantly lower PPTs in all tested locations and less active cervical range of motion than controls (P<.001). In the patient group, there were significant negative correlations between the number of active TrPs and PPT over the C5-C6 joints and cervical range of motion in flexion, extension, and rotation in both directions: the greater the number of active TrPs, the lower the bilateral PPT over the neck and the greater the cervical range of motion limitation.
CONCLUSIONS: The local and referred pain elicited from active TrPs reproduced neck and shoulder pain patterns in individuals with acute WADs with higher levels of disability. Patients with acute WADs exhibited widespread pressure hypersensitivity and reduced cervical mobility. The number of active TrPs was related to higher neck pain intensity, the number of days since the accident, higher pressure pain hypersensitivity over the cervical spine, and reduced active cervical range of motion.

Entities:  

Mesh:

Year:  2012        PMID: 22677576     DOI: 10.2519/jospt.2012.4117

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  10 in total

1.  Effect of Neck Strength on Simulated Head Impacts During Falls in Female Ice Hockey Players.

Authors:  Brittany Pennock; Derek Kivi; Carlos Zerpa
Journal:  Int J Exerc Sci       Date:  2021-04-01

2.  Intra-articular nerve growth factor regulates development, but not maintenance, of injury-induced facet joint pain & spinal neuronal hypersensitivity.

Authors:  J V Kras; S Kartha; B A Winkelstein
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

3.  Acute Whiplash Injury Study (AWIS): a protocol for a cluster randomised pilot and feasibility trial of an Active Behavioural Physiotherapy Intervention in an insurance private setting.

Authors:  Taweewat Wiangkham; Joan Duda; M Sayeed Haque; Jonathan Price; Alison Rushton
Journal:  BMJ Open       Date:  2016-07-13       Impact factor: 2.692

Review 4.  Thoracic dysfunction in whiplash associated disorders: A systematic review.

Authors:  Nicola R Heneghan; Richard Smith; Isaak Tyros; Deborah Falla; Alison Rushton
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

5.  A cluster randomised, double-blind pilot and feasibility trial of an active behavioural physiotherapy intervention for acute whiplash-associated disorder (WAD)II.

Authors:  Taweewat Wiangkham; Joan Duda; M Sayeed Haque; Jonathan Price; Alison Rushton
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

Review 6.  Current Concept of Quantitative Sensory Testing and Pressure Pain Threshold in Neck/Shoulder and Low Back Pain.

Authors:  Hidenori Suzuki; Shu Tahara; Mao Mitsuda; Hironori Izumi; Satoshi Ikeda; Kazushige Seki; Norihiro Nishida; Masahiro Funaba; Yasuaki Imajo; Kiminori Yukata; Takashi Sakai
Journal:  Healthcare (Basel)       Date:  2022-08-07

7.  Inter and Intra Operator Reliability of Motor and Palpation Evaluation in Fascial Manipulation in individuals with coxarthrosis.

Authors:  Andrea Cotti; Massimiliano Del Corso; Roberto Diana; Luigi Cornale; Alessandra Sudanese; Antonio Stecco; Mirco Branchini
Journal:  J Man Manip Ther       Date:  2019-10-31

8.  Validation of the German version of the Neck Disability Index (NDI).

Authors:  Holger Cramer; Romy Lauche; Jost Langhorst; Gustav J Dobos; Andreas Michalsen
Journal:  BMC Musculoskelet Disord       Date:  2014-03-19       Impact factor: 2.362

9.  The prevalence of myofascial trigger points in neck and shoulder-related disorders: a systematic review of the literature.

Authors:  Daniel Cury Ribeiro; Angus Belgrave; Ana Naden; Helen Fang; Patrick Matthews; Shayla Parshottam
Journal:  BMC Musculoskelet Disord       Date:  2018-07-25       Impact factor: 2.362

10.  Isometric muscle fatigue of the paravertebral and upper extremity muscles after whiplash injury.

Authors:  Pejana Rastovic; Marija Definis Gojanovic; Marina Berberovic; Marko Pavlovic; Josip Lesko; Gordan Galic; Maja Pandza
Journal:  Ann Saudi Med       Date:  2017 Jul-Aug       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.